Update on pathophysiologic mechanisms of human papillomavirus

Current Opinion in Obstetrics and Gynecology

Volumn 17, Issue 1, 2005, Pages 61-64

  Moodley, Manivasan ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Chromosomal aneuploidy; Human papillomavirus oncogenes

Indexed keywords

ANEUPLOIDY; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; NEOPLASM; ONCOGENE; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; WART VIRUS;

EID: 14644442932     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-200502000-00011     Document Type: Review

References (28)

1. Bekkers RL, Massuger LF, Bulten J, Melchera WJ. Epidemiological and clinical aspects of human papillomairus deletion in the prevention of cervical cancer. Rev Med Virol 2004; 14:95-105.
2. Cottage A, Dowen S, Roberts I, et al. Early genetic events in HPV immortalized keratinocytes. Genes Chromosomes Cancer 2001; 30:72-79.
3. Cooper K, Evans M, Mount S. Bioiogy and evolution of cervical squamous intraepithelial lesions: a hypothesis with diagnostic prognostic implications. Adv Anat Pathol 2003; 10:200-203.
4. Hudelist G, Manavi M, Pishchinger KI, et al. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol Oncol 2004; 92:873-880.
5. Wentzensen N, Vinkurova S, von Knebel Doeberitz M. Systemic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 2004; 64:3878-3884.
6. Melsheimer P, Vinokurova S, Wentzensen N, et al. DNA aneuploidy and integration of human papillomavirus type 16 E6/E7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri. Clin Cancer Res 2004; 10:3059-3063.
7. Martens JE, Arends J, van der Linden PJ, et al. Cytokeratin 17 and p63 are markers of the HPV target cell, the cervical stem cell. Anticancer Res 2004; 24:771-775.
8. Steenbergen RD, Kramer D, Braakhuis BJ, et al. TSLC 1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst 2004; 18:294-305.
9. Kirkpatrick A, Bidwell J, van den Brule AJ, et al. TNFalpha polymorphism frequencies in HPV-associated cervical dysplasia. Gynecol Oncol 2004; 92:675-679.
10. Badal V, Chuang LS, Tan EH, et al. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol 2003; 77:6227-6234.
11. Luxton JC, Nath R, Derias N, et al. Human papillomavirus type 16-specific T cell responses and their association with recurrence of cervical disease following treatment. J Gen Virol 2003; 84:1063-1070.
12. Jee SH, Um SJ, Lee JE, et al. The effect of codon 98 of the FHIT gene on cervical caner in Korean women. Int J Gynecol Cancer 2003; 13:843-848.
13. Southern SA, Lewis MH, Herrington CS. Induction of tetrasomy by human papillomavirus type 16 E7 protein is independent of pRb binding and disruption of differentiation. Br J Cancer 2004; 90:1949-1954.
14. Okubo M, Saito M, Inoku H, et al. Analysis of HLA-DRBI *0901-binding HPV16 E7 helper T cell epitope. J Obstet Gynecol Res 2004; 30:120-129.
15. Jarboe EA, Thompson LC, Heinz D, et al. Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma. Hum Pathol 2004; 35:393-395.
16. Plummer M, Herrero R, Franceschi S, et al. Smoking and cervical cancer: pooled analysis of the IARCH multi-centric case-control study. Cancer Causes Control 2003; 14:805-814.
17. Harris TG, Kulasingam SL, Kiviat NB, et al. Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen and cervical intraepithelial neoplasia. Am J Epidemiol 2004; 159:834-842.
18. Moodley M, Moodley J, Chetty R, et al. The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review. Int J Gynecol Cancer 2003; 13:103-110. An exhaustive review of the role of steroid contraception in the pathogenesis of cervical cancer. The review discusses the molecular link between human papillomavirus and steroid contraception.
19. Moodley M, Sewart S, Herrington CS, et al. The interaction between steroid hormones, human papillomavirus type 16, E6 oncogene expression and cervical cancer. Int J Gynecol Cancer 2003; 13:834-842.
20. Levi JE, Kleter B, Quint WG, et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002; 40:3341-3345.
21. Goncalves MA, Soares EG, Fernades AP, et al. Langerhan's cell count and HLA class II profile in cervical intraepithelial neoplasia in the presence or absence of HIV infection. Eur J Obstet Gynecol Reprod Biol 2004; 114:221-227.
22. Hagenesee ME, Cameron JE, Leigh JE, Clark RA. Human papillomavirus infection and disease in HIV-infected individuals. Am J Med Sci 2004; 328:57-63.
23. Heard I. Cervical disease and cancer in HIV positive women. Recommendations for screening and diagnosis. Med Wieku Rozwo 2003; 7:479-485.
24. Branca M, Garbuglia AR, Benedetto A, et al. Factors predicting the persistence of genital human papilomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up. Int J STD AIDS 2003; 14:417-425.
25. Schuman P, Ohrnit SE, Klein RS, et al. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV) seropositive and at-risk HIV-seronegative women. J Infect Dis 2003; 188:128-136.
26. Conti M, Agarossi A, Parazzini F, et al. HPV, HIV infection and risk of cervical intraepithelial neoplasia in former intravenous drug abusers. Gynecol Oncol 1993; 49:344-348.
27. Heard I, Tassie JM, Schmitz V, et al. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load. Obstet Gynecol 2000; 96:403-409.
28. Clarke B, Chetty R. Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer. Mol Pathol 2002; 55:19-24.